84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Biosimulation Market to Reach a Capital Expenditure of USD 10.1 in 2032 | CAGR of 13.7%
25 avr. 2023 14h37 HE | Market.Us
New York, April 25, 2023 (GLOBE NEWSWIRE) -- As per the latest finding of Market.us, Biosimulation Market Revenue is expected to be USD 2.9 by the end of 2022. In the long term, the market is...
DBMR Logo.png
Biotechnology Market is Expected to Reach the Valuation of USD 10129.16 Billion by 2030, Size, Share, Growth, Trends, Demand and Opportunity Analysis
28 févr. 2023 07h30 HE | Data Bridge Market Research
NEW YORK, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market research has recently published comprehensive business research on “Biotechnology Market" including historic data, present market...
visiongain Logo.png
Biosimilars and Follow-on Biologics market is projected to grow at a CAGR of 31.14% by 2033: Visiongain Reports Ltd
13 janv. 2023 10h28 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Biosimilars and Follow-on Biologics 2023-2033. It includes profiles of Biosimilars and Follow-on Biologics and Forecasts Market Segment by Type of...
factMR-logo.png
Pressing Concerns about Depleting Fossil Fuel Reserves to Raise Need for Biorefineries, Increase in Demand for Bio-Based Polymers to Achieve Net-Zero Emissions Is Expected To Propel the Market: Fact.MR Report
04 janv. 2023 07h30 HE | FACT.MR
Rockville, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The global biorefinery market is likely to achieve a valuation of US$ 340 billion by 2033, rapidly expanding at a 9% CAGR from 2023 to 2033, according to...
visiongain Logo.png
Global Single Cell Analysis Market is Projected to Grow at a CAGR of 15.1% By 2032: Visiongain Reports Ltd
14 déc. 2022 06h00 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled the Single Cell Analysis 2022-2032. It includes profiles of Single Cell Analysis and Forecasts Market Segment by Type (Consumables, Instruments) Market...
visiongain Logo.png
Mesenchymal stem cells market is projected to grow at a CAGR of 13.82% by 2032: Visiongain Reports Ltd
14 déc. 2022 06h00 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Mesenchymal Stem Cells Market 2022-2032. It includes profiles of Mesenchymal Stem Cells Market and Forecasts Market Segment by Type {Product (Cell &...
visiongain Logo.png
Biosimilars and Follow-on Biologics market is projected to grow at a CAGR of 31.14% by 2033: Visiongain Reports Ltd
08 déc. 2022 12h23 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Biosimilars and Follow-on Biologics 2023-2033. It includes profiles of Biosimilars and Follow-on Biologics and Forecasts Market Segment by Type of...
visiongain Logo.png
Gene therapy R&D market is projected to grow at a CAGR of 30.1% by 2032: Visiongain Reports Ltd
29 nov. 2022 12h29 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Gene Therapy R&D 2022-2032. It includes profiles of Gene Therapy R&D and Forecasts Market Segment by Disease {Cancer, Rare Diseases (Oncologic,...
visiongain Logo.png
3D Cell Culture and 3D Bioprinting Market Report Up to 2032: Visiongain Reports Ltd
09 nov. 2022 11h31 HE | Visiongain Reports Ltd
Visiongain has launched a new report 3D Cell Culture and 3D Bioprinting Market Report 2022-2032: Forecasts by Technology (Scaffold-Based, Scaffold-Free, Microfluidics-based, Magnetic Levitation, 3D...
visiongain Logo.png
Global biosimilar monoclonal antibodies market is projected to grow at a CAGR of 23.5% by 2032: Visiongain Reports Ltd
14 oct. 2022 06h00 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Biosimilar Monoclonal Antibodies 2022-2032. It includes profiles of Biosimilar Monoclonal Antibodies and Forecasts Market Segment by Type (Synthetic...